tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thomas Shrader, 145 are a BUY (90.06%), 15 are a HOLD (9.32%), 1 are a SELL (0.62%).
Analyst Thomas Shrader, currently employed at BTIG, carries an average stock price target met ratio of 52.39% that have a potential upside of 47.79% achieved within 260 days.
Thomas Shrader’s has documented 306 price targets and ratings displayed on 45 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on DNLI, Denali Therapeutics at 05-Dec-2025.
Analyst best performing recommendations are on VRNA (VERONA PHARMA PLC ADR).
The best stock recommendation documented was for VRNA (VERONA PHARMA PLC ADR) at 12/20/2022. The price target of $26 was fulfilled within 10 days with a profit of $7.41 (39.86%) receiving and performance score of 39.86.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 20-Aug-2019
$86
$8.75 (11.33%)
$46
28 days ago
(15-Dec-2025)
17/18 (94.44%)
$10.85 (14.44%)
528
Buy
Since 22-Jul-2019
$77
$-0.25 (-0.32%)
$70
2 months 5 days ago
(07-Nov-2025)
16/16 (100%)
$15.2 (24.60%)
262
Buy
Since 13-Apr-2020
$90
$12.75 (16.50%)
$90
2 months 9 days ago
(03-Nov-2025)
26/31 (83.87%)
$28.02 (45.21%)
275
Buy
Since 04-Sep-2024
$98
$20.75 (26.86%)
$68
2 months 13 days ago
(30-Oct-2025)
3/4 (75%)
$34.63 (54.65%)
207
Buy
Since 19-Apr-2023
$110
$32.75 (42.39%)
$95
2 months 13 days ago
(30-Oct-2025)
8/11 (72.73%)
$46.63 (73.58%)
500
Which stock is Thomas Shrader is most bullish on?
Which stock is Thomas Shrader is most reserved on?
What Year was the first public recommendation made by Thomas Shrader?
